Ferring Inc. v. Canada (Health)
Source text
Ferring Inc. v. Canada (Health) Court (s) Database Federal Court of Appeal Decisions Date 2007-09-06 Neutral citation 2007 FCA 276 File numbers A-198-07 Notes Digest Decision Content Date: 20070906 Docket: A-198-07 Citation: 2007 FCA 276 CORAM: RICHARD C.J. SEXTON J.A. SHARLOW J.A. Docket: A-198-07 BETWEEN: FERRING INC. Appellant and THE MINISTER OF HEALTH, APOTEX INC. and NOVOPHARM LIMITED Respondents Docket: A-161-07 BETWEEN: SANOFI-AVENTIS CANADA INC. Appellant and MINISTER OF HEALTH, THE ATTORNEY GENERAL OF CANADA and APOTEX INC. Respondents Docket: A-162-07 BETWEEN: SANOFI-AVENTIS CANADA INC. Appellant and MINISTER OF HEALTH, THE ATTORNEY GENERAL OF CANADA and APOTEX INC. Respondents Docket: A-163-07 BETWEEN: SANOFI-AVENTIS CANADA INC. Appellant and MINISTER OF HEALTH, THE ATTORNEY GENERAL OF CANADA and NOVOPHARM LIMITED Respondents Heard at Ottawa, Ontario, on September 4, 5 and 6, 2007. Judgment delivered from the Bench at Ottawa, Ontario, on September 6, 2007. REASONS FOR JUDGMENT OF THE COURT BY: RICHARD C.J. Date: 20070906 Docket: A-198-07 Citation: 2007 FCA 276 CORAM: RICHARD C.J. SEXTON J.A. SHARLOW J.A. Docket: A-198-07 BETWEEN: FERRING INC. Appellant and THE MINISTER OF HEALTH, APOTEX INC. and NOVOPHARM LIMITED Respondents Docket: A-161-07 BETWEEN: SANOFI-AVENTIS CANADA INC. Appellant and MINISTER OF HEALTH, THE ATTORNEY GENERAL OF CANADA and APOTEX INC. Respondents Docket: A-162-07 BETWEEN: SANOFI-AVENTIS CANADA INC. Appellant and MINISTER OF HEALTH, THE ATTORN…
Full judgment (source text)
Mirrored from decisions.fca-caf.gc.ca — the linked original is authoritative.
Ferring Inc. v. Canada (Health) Court (s) Database Federal Court of Appeal Decisions Date 2007-09-06 Neutral citation 2007 FCA 276 File numbers A-198-07 Notes Digest Decision Content Date: 20070906 Docket: A-198-07 Citation: 2007 FCA 276 CORAM: RICHARD C.J. SEXTON J.A. SHARLOW J.A. Docket: A-198-07 BETWEEN: FERRING INC. Appellant and THE MINISTER OF HEALTH, APOTEX INC. and NOVOPHARM LIMITED Respondents Docket: A-161-07 BETWEEN: SANOFI-AVENTIS CANADA INC. Appellant and MINISTER OF HEALTH, THE ATTORNEY GENERAL OF CANADA and APOTEX INC. Respondents Docket: A-162-07 BETWEEN: SANOFI-AVENTIS CANADA INC. Appellant and MINISTER OF HEALTH, THE ATTORNEY GENERAL OF CANADA and APOTEX INC. Respondents Docket: A-163-07 BETWEEN: SANOFI-AVENTIS CANADA INC. Appellant and MINISTER OF HEALTH, THE ATTORNEY GENERAL OF CANADA and NOVOPHARM LIMITED Respondents Heard at Ottawa, Ontario, on September 4, 5 and 6, 2007. Judgment delivered from the Bench at Ottawa, Ontario, on September 6, 2007. REASONS FOR JUDGMENT OF THE COURT BY: RICHARD C.J. Date: 20070906 Docket: A-198-07 Citation: 2007 FCA 276 CORAM: RICHARD C.J. SEXTON J.A. SHARLOW J.A. Docket: A-198-07 BETWEEN: FERRING INC. Appellant and THE MINISTER OF HEALTH, APOTEX INC. and NOVOPHARM LIMITED Respondents Docket: A-161-07 BETWEEN: SANOFI-AVENTIS CANADA INC. Appellant and MINISTER OF HEALTH, THE ATTORNEY GENERAL OF CANADA and APOTEX INC. Respondents Docket: A-162-07 BETWEEN: SANOFI-AVENTIS CANADA INC. Appellant and MINISTER OF HEALTH, THE ATTORNEY GENERAL OF CANADA and APOTEX INC. Respondents Docket: A-163-07 BETWEEN: SANOFI-AVENTIS CANADA INC. Appellant and MINISTER OF HEALTH, THE ATTORNEY GENERAL OF CANADA and NOVOPHARM LIMITED Respondents REASONS FOR JUDGMENT OF THE COURT (Delivered from the Bench at Ottawa, Ontario, on September 6, 2007) RICHARD C.J. [1] These four appeals, heard together, are from judgments of Justice Hughes of the Federal Court rendered on March 20, 2007 (2007 FC 300). His decision disposed of four applications for judicial review of decisions of the Minister of Health resulting in the issuance of notices of compliance that permit the respondents Apotex Inc. and Novopharm Limited to manufacture and market generic versions of certain drug products. [2] The appellants Ferring Inc. and Sanofi-Aventis Canada Inc., the unsuccessful applicants in the Federal Court, are innovators of the drug products to which Apotex and Novopharm compared their generic drug products when seeking their notices of compliances. In the Federal Court and in this Court, the innovators have argued on a number of grounds that the Minister was wrong to issue notices of compliance to Apotex and Novopharm without first requiring them to address, under the Patented Medicines (Notice of Compliance) Regulations, certain patents listed on the patent register after Apotex and Novopharm had filed their respective abbreviated new drug submissions. [3] Much of the argument on appeal was based on the interpretation and application of subsection 5(1) of the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133 following the decision of the Supreme Court of Canada in AstraZeneca Canada Inc. v. Canada (Minister of Health), [2006] 2 S.C.R. 560, 2006 S.C.C. 49. These regulations were amended by SOR/2006-242 effective October 5, 2006 and introduce a new regime. [4] We do not consider it necessary to discuss the arguments in detail because we are in substantial agreement with the decision of Justice Hughes and with his reasons. [5] We differ from Justice Hughes on only one point. As an alternative basis for dismissing the application of Ferring Inc., Justice Hughes concluded that Ferring Inc. did not have standing to bring an application for judicial review of the decision of the Minister. We do not agree. In our view, Ferring Inc. did have standing to challenge that decision because it was made by the Minister in the course of his administration of the NOC Regulations. However, that does not alter the outcome because Justice Hughes dismissed the application of Ferring Inc. on the merits. [6] We have concluded that the analytical approach adopted by the Minister in these four appeals was adequate for the factual circumstances of these cases. Whether it is adequate for all possible circumstances, including the circumstances of appeal A‑189‑07, which has been dismissed on the ground of mootness, is a question upon which we express no opinion. [7] We also note that there remains some confusion about the appropriate standard of review to be applied by the Federal Court in an application for judicial review of a determination by the Minister that a generic drug manufacturer is not required to address a particular patent under the NOC Regulations. In our view, the standard of review is correctness for questions of law, and patent unreasonableness for questions of fact (AstraZeneca Canada Inc. v. Canada (Minister of Health), 2004 FC 1277, per Justice Kelen at paragraph 33). [8] I would add that where there is a mixed question of law and fact then the standard of review is patent unreasonableness unless the question of law is extricable from the question of fact in which case the question of law is determined on the basis of correctness. [9] Accordingly, these appeals will be dismissed with costs. [10] A copy of these reasons shall be filed in Court File Numbers A-161-07, A-162-07 and A‑163-07. "J. Richard" Chief Justice FEDERAL COURT OF APPEAL NAMES OF COUNSEL AND SOLICITORS OF RECORD DOCKET: A-198-07 APPEAL FROM A DECISION OF JUSTICE HUGHES DATED MARCH 20, 2007 IN FILE T-165-07 STYLE OF CAUSE: Ferring Inc. v. Minister of Health, Apotex Inc. and Novopharm Limited PLACE OF HEARING: Ottawa DATES OF HEARING: September 4, 5 and 6, 2007 REASONS FOR JUDGMENT OF THE COURT BY: Richard C.J. DELIVERED FROM THE BENCH BY: Richard C.J. APPEARANCES: Mr. Jason Markwell Ms. Kristin Wall FOR THE APPELLANT Mr. Rick Woyiwada Mr. David Cowie Mr. Harry Radomski Mr. Benjamin Hackett Mr. Miles Hastie Mr. Jeffrey Leon Mr. Robert Staley Ms. Dominique Hussey FOR THE MINISTER OF HEALTH AND AGC FOR APOTEX INC. FOR NOVOPHARM LIMITED SOLICITORS OF RECORD: Ogilvy Renault LLP, Toronto, Ontario FOR THE APPELLANT John Sims, Deputy Attorney General of Canada, Ottawa, Ontario Goodmans LLP, Toronto, Ontario Bennett Jones LLP, Toronto, Ontario FOR THE MINISTER OF HEALTH AND AGC FOR APOTEX INC. FOR NOVOPHARM LIMITED FEDERAL COURT OF APPEAL NAMES OF COUNSEL AND SOLICITORS OF RECORD DOCKET: A-161-07 APPEAL FROM A DECISION OF JUSTICE HUGHES DATED MARCH 27, 2007 STYLE OF CAUSE: Sanofi-Avenis Canada Inc. v. Minister of Health, Attorney General of Canada and Apotex Inc. PLACE OF HEARING: Ottawa DATES OF HEARING: September 4, 5 and 6, 2007 REASONS FOR JUDGMENT OF THE COURT BY: Richard C.J. DELIVERED FROM THE BENCH BY: Richard C.J. APPEARANCES: Mr. Gunars Gaikis Mr. David Morrow Ms. Nancy Pei Ms. Yoon Kang FOR THE APPELLANT Mr. Rick Woyiwada Mr. David Cowie Mr. Harry Radomski Mr. Benjamin Hackett Mr. Miles Hastie FOR THE MINISTER OF HEALTH AND AGC FOR APOTEX INC. SOLICITORS OF RECORD: Smart & Biggar, Toronto, Ontario FOR THE APPELLANT John Sims, Deputy Attorney General of Canada, Ottawa, Ontario Goodmans LLP, Toronto, Ontario FOR THE MINISTER OF HEALTH AND AGC FOR APOTEX INC. FEDERAL COURT OF APPEAL NAMES OF COUNSEL AND SOLICITORS OF RECORD DOCKET: A-162-07 APPEAL FROM A DECISION OF JUSTICE HUGHES DATED MARCH 27, 2007 STYLE OF CAUSE: Sanofi-Avenis Canada Inc. v. Minister of Health, Attorney General of Canada and Apotex Inc. PLACE OF HEARING: Ottawa DATES OF HEARING: September 4, 5 and 6, 2007 REASONS FOR JUDGMENT OF THE COURT BY: Richard C.J. DELIVERED FROM THE BENCH BY: Richard C.J. APPEARANCES: Mr. Gunars Gaikis Mr. David Morrow Ms. Nancy Pei Ms. Yoon Kang FOR THE APPELLANT Mr. Rick Woyiwada Mr. David Cowie Mr. Harry Radomski Mr. Benjamin Hackett Mr. Miles Hastie FOR THE MINISTER OF HEALTH AND AGC FOR APOTEX INC. SOLICITORS OF RECORD: Smart & Biggar, Toronto, Ontario FOR THE APPELLANT John Sims, Deputy Attorney General of Canada, Ottawa, Ontario Goodmans LLP, Toronto, Ontario FOR THE MINISTER OF HEALTH AND AGC FOR APOTEX INC. FEDERAL COURT OF APPEAL NAMES OF COUNSEL AND SOLICITORS OF RECORD DOCKET: A-163-07 APPEAL FROM A DECISION OF JUSTICE HUGHES DATED MARCH 20, 2007 IN FILE T-2188-06 STYLE OF CAUSE: Sanofi-Avenis Canada Inc. v. Minister of Health, Attorney General of Canada and Novopharm Limited PLACE OF HEARING: Ottawa DATES OF HEARING: September 4, 5 and 6, 2007 REASONS FOR JUDGMENT OF THE COURT BY: Richard C.J. DELIVERED FROM THE BENCH BY: Richard C.J. APPEARANCES: Mr. Gunars Gaikis Mr. David Morrow Ms. Nancy Pei Ms. Yoon Kang FOR THE APPELLANT Mr. Rick Woyiwada Mr. David Cowie Mr. Jeffrey Leon Mr. Robert Staley Ms. Dominique Hussey FOR THE MINISTER OF HEALTH AND AGC FOR NOVOPHARM LIMITED SOLICITORS OF RECORD: Smart & Biggar, Toronto, Ontario FOR THE APPELLANT John Sims, Deputy Attorney General of Canada, Ottawa, Ontario Bennett Jones LLP, Toronto, Ontario FOR THE MINISTER OF HEALTH AND AGC FOR NOVOPHARM LIMITED
Source: decisions.fca-caf.gc.ca
Klouvi c. Canada (Procureur général)
2024 CAF 80